GEMCITABINE, Mrtx1719 matching placebo, PACLITAXEL ALBUMIN-BOUND, MRTX1719
CA240-0030
Phase 3 small_molecule active
Quick answer
GEMCITABINE, Mrtx1719 matching placebo, PACLITAXEL ALBUMIN-BOUND, MRTX1719 for Untreated Metastatic Pancreatic Ductal Adenocarcinoma is a Phase 3 program (small_molecule) at Bristol-Myers Squibb / Pfizer EEIG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bristol-Myers Squibb / Pfizer EEIG
- Indication
- Untreated Metastatic Pancreatic Ductal Adenocarcinoma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active